Simulations Plus Price to Sales Ratio 2010-2025 | SLP
Historical PS ratio values for Simulations Plus (SLP) over the last 10 years. The current P/S ratio for Simulations Plus as of July 17, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Simulations Plus P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-07-17 |
12.79 |
|
3.22 |
| 2025-05-31 |
31.85 |
$3.97 |
8.02 |
| 2025-02-28 |
28.98 |
$3.87 |
7.49 |
| 2024-11-30 |
31.77 |
$3.66 |
8.68 |
| 2024-08-31 |
36.25 |
$3.44 |
10.53 |
| 2024-05-31 |
48.17 |
$3.29 |
14.65 |
| 2024-02-29 |
41.38 |
$3.18 |
13.02 |
| 2023-11-30 |
39.03 |
$3.04 |
12.82 |
| 2023-08-31 |
44.22 |
$2.90 |
15.23 |
| 2023-05-31 |
43.87 |
$2.70 |
16.22 |
| 2023-02-28 |
37.71 |
$2.63 |
14.35 |
| 2022-11-30 |
40.18 |
$2.57 |
15.61 |
| 2022-08-31 |
59.35 |
$2.60 |
22.85 |
| 2022-05-31 |
46.88 |
$2.51 |
18.70 |
| 2022-02-28 |
38.84 |
$2.40 |
16.18 |
| 2021-11-30 |
46.25 |
$2.32 |
19.95 |
| 2021-08-31 |
43.55 |
$2.23 |
19.49 |
| 2021-05-31 |
51.82 |
$2.27 |
22.79 |
| 2021-02-28 |
70.35 |
$2.33 |
30.23 |
| 2020-11-30 |
54.86 |
$2.26 |
24.26 |
| 2020-08-31 |
58.35 |
$2.26 |
25.81 |
| 2020-05-31 |
49.58 |
$2.19 |
22.63 |
| 2020-02-29 |
31.81 |
$2.07 |
15.35 |
| 2019-11-30 |
32.59 |
$1.98 |
16.48 |
| 2019-08-31 |
35.15 |
$1.88 |
18.67 |
| 2019-05-31 |
24.37 |
$1.81 |
13.44 |
| 2019-02-28 |
19.88 |
$1.74 |
11.42 |
| 2018-11-30 |
19.15 |
$1.68 |
11.38 |
| 2018-08-31 |
20.09 |
$1.66 |
12.10 |
| 2018-05-31 |
18.44 |
$1.64 |
11.22 |
| 2018-02-28 |
14.88 |
$1.55 |
9.61 |
| 2017-11-30 |
14.83 |
$1.46 |
10.12 |
| 2017-08-31 |
13.77 |
$1.38 |
9.98 |
| 2017-05-31 |
11.55 |
$1.25 |
9.23 |
| 2017-02-28 |
9.10 |
$1.22 |
7.48 |
| 2016-11-30 |
8.87 |
$1.19 |
7.46 |
| 2016-08-31 |
8.04 |
$1.16 |
6.94 |
| 2016-05-31 |
7.09 |
$1.15 |
6.18 |
| 2016-02-29 |
8.82 |
$1.15 |
7.70 |
| 2015-11-30 |
8.20 |
$1.11 |
7.36 |
| 2015-08-31 |
6.16 |
$1.07 |
5.75 |
| 2015-05-31 |
5.34 |
$0.98 |
5.47 |
| 2015-02-28 |
5.71 |
$0.86 |
6.68 |
| 2014-11-30 |
5.67 |
$0.78 |
7.30 |
| 2014-08-31 |
5.94 |
$0.70 |
8.50 |
| 2014-05-31 |
5.30 |
$0.67 |
7.87 |
| 2014-02-28 |
4.96 |
$0.64 |
7.80 |
| 2013-11-30 |
4.33 |
$0.64 |
6.79 |
| 2013-08-31 |
4.09 |
$0.62 |
6.64 |
| 2013-05-31 |
3.73 |
$0.62 |
6.01 |
| 2013-02-28 |
3.39 |
$0.60 |
5.64 |
| 2012-11-30 |
3.72 |
$0.59 |
6.35 |
| 2012-08-31 |
3.61 |
$0.58 |
6.17 |
| 2012-05-31 |
3.16 |
$0.60 |
5.30 |
| 2012-02-29 |
3.17 |
$0.59 |
5.35 |
| 2011-11-30 |
2.40 |
$0.58 |
4.14 |
| 2011-08-31 |
2.52 |
$0.56 |
4.46 |
| 2011-05-31 |
2.26 |
$0.58 |
3.87 |
| 2011-02-28 |
2.57 |
$0.61 |
4.24 |
| 2010-11-30 |
2.32 |
$0.62 |
3.72 |
| 2010-08-31 |
1.92 |
$0.64 |
2.98 |
| 2010-05-31 |
1.88 |
$0.64 |
2.92 |
| 2010-02-28 |
1.30 |
$0.62 |
2.10 |
| 2009-11-30 |
1.10 |
$0.58 |
1.88 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.260B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
